Clinical trials
Phase 3 Hepatitis B, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 6 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Unknown status | 15 |
| Terminated | 7 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 11 |
| Gilead Sciences | 8 |
| GlaxoSmithKline | 8 |
| Hoffmann-La Roche | 6 |
| Novartis | 5 |
| Novartis Pharmaceuticals | 5 |
| Merck Sharp & Dohme LLC | 3 |
| Fujian Akeylink Biotechnology Co., Ltd. | 2 |
| IlDong Pharmaceutical Co Ltd | 2 |
| Xiamen Amoytop Biotech Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 80 |
| Hepatitis B | 18 |
| Hepatitis | 3 |
| HIV Infections | 2 |
| Hepatitis, Chronic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arthritis, Juvenile | 1 |
| Arthritis, Psoriatic | 1 |
| Arthritis, Rheumatoid | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 76 to 80 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.